Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinodasertib in Metastatic Colorectal Cancer
NCT05462236Phase 2Recruiting
- Sponsor
- AUM Biosciences
- Start
- Apr 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tinodasertib in colorectal cancer (CRC), sponsored by AUM Biosciences. Started Apr 2023; status: recruiting.
02
Drugs
tinodasertib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05462236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05462236.